<!DOCTYPE html>
<!-- Generated by pkgdown: do not edit by hand --><html lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta charset="utf-8"><meta http-equiv="X-UA-Compatible" content="IE=edge"><meta name="viewport" content="width=device-width, initial-scale=1.0"><title>Select dose by the CIBP selection criterion. — select_dose_by_cibp • escalation</title><!-- favicons --><link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png"><link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png"><link rel="apple-touch-icon" type="image/png" sizes="180x180" href="../apple-touch-icon.png"><link rel="apple-touch-icon" type="image/png" sizes="120x120" href="../apple-touch-icon-120x120.png"><link rel="apple-touch-icon" type="image/png" sizes="76x76" href="../apple-touch-icon-76x76.png"><link rel="apple-touch-icon" type="image/png" sizes="60x60" href="../apple-touch-icon-60x60.png"><!-- jquery --><script src="https://cdnjs.cloudflare.com/ajax/libs/jquery/3.7.1/jquery.min.js" integrity="sha512-v2CJ7UaYy4JwqLDIrZUI/4hqeoQieOmAZNXBeQyjo21dadnwR+8ZaIJVT8EE2iyI61OV8e6M8PP2/4hpQINQ/g==" crossorigin="anonymous" referrerpolicy="no-referrer"></script><!-- Bootstrap --><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/twitter-bootstrap/3.4.1/css/bootstrap.min.css" integrity="sha256-bZLfwXAP04zRMK2BjiO8iu9pf4FbLqX6zitd+tIvLhE=" crossorigin="anonymous"><script src="https://cdnjs.cloudflare.com/ajax/libs/twitter-bootstrap/3.4.1/js/bootstrap.min.js" integrity="sha256-nuL8/2cJ5NDSSwnKD8VqreErSWHtnEP9E7AySL+1ev4=" crossorigin="anonymous"></script><!-- bootstrap-toc --><link rel="stylesheet" href="../bootstrap-toc.css"><script src="../bootstrap-toc.js"></script><!-- Font Awesome icons --><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/all.min.css" integrity="sha256-mmgLkCYLUQbXn0B1SRqzHar6dCnv9oZFPEC1g1cwlkk=" crossorigin="anonymous"><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/v4-shims.min.css" integrity="sha256-wZjR52fzng1pJHwx4aV2AO3yyTOXrcDW7jBpJtTwVxw=" crossorigin="anonymous"><!-- clipboard.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/2.0.6/clipboard.min.js" integrity="sha256-inc5kl9MA1hkeYUt+EC3BhlIgyp/2jDIyBLS6k3UxPI=" crossorigin="anonymous"></script><!-- headroom.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/headroom.min.js" integrity="sha256-AsUX4SJE1+yuDu5+mAVzJbuYNPHj/WroHuZ8Ir/CkE0=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/jQuery.headroom.min.js" integrity="sha256-ZX/yNShbjqsohH1k95liqY9Gd8uOiE1S4vZc+9KQ1K4=" crossorigin="anonymous"></script><!-- pkgdown --><link href="../pkgdown.css" rel="stylesheet"><script src="../pkgdown.js"></script><meta property="og:title" content="Select dose by the CIBP selection criterion. — select_dose_by_cibp"><meta property="og:description" content="This method selects dose by the convex infinite bounds penalisation (CIBP)
criterion of Mozgunov &amp;amp; Jaki. Their method is mindful of the uncertainty in
the estimates of the probability of toxicity and uses an asymmetry parameter
to penalise escalation to risky doses."><meta property="og:image" content="/logo.png"><!-- mathjax --><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/MathJax.js" integrity="sha256-nvJJv9wWKEm88qvoQl9ekL2J+k/RWIsaSScxxlsrv8k=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/config/TeX-AMS-MML_HTMLorMML.js" integrity="sha256-84DKXVJXs0/F8OTMzX4UR909+jtl4G7SPypPavF+GfA=" crossorigin="anonymous"></script><!--[if lt IE 9]>
<script src="https://oss.maxcdn.com/html5shiv/3.7.3/html5shiv.min.js"></script>
<script src="https://oss.maxcdn.com/respond/1.4.2/respond.min.js"></script>
<![endif]--></head><body data-spy="scroll" data-target="#toc">


    <div class="container template-reference-topic">
      <header><div class="navbar navbar-default navbar-fixed-top" role="navigation">
  <div class="container">
    <div class="navbar-header">
      <button type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-target="#navbar" aria-expanded="false">
        <span class="sr-only">Toggle navigation</span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
      </button>
      <span class="navbar-brand">
        <a class="navbar-link" href="../index.html">escalation</a>
        <span class="version label label-default" data-toggle="tooltip" data-placement="bottom" title="">0.2.2.9023</span>
      </span>
    </div>

    <div id="navbar" class="navbar-collapse collapse">
      <ul class="nav navbar-nav"><li>
  <a href="../reference/index.html">Reference</a>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    Articles

    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu"><li>
      <a href="../articles/A100-DoseSelectors.html">Using escalation</a>
    </li>
    <li>
      <a href="../articles/A205-CRM.html">CRM - Continual Reassessment Method</a>
    </li>
    <li>
      <a href="../articles/A207-NBG.html">NBG - Neuenschwander, Branson &amp; Gsponer</a>
    </li>
    <li>
      <a href="../articles/A210-TPI.html">TPI - Toxicity Probability Interval Design</a>
    </li>
    <li>
      <a href="../articles/A220-mTPI.html">mTPI - Modified Toxicity Probability Interval Design</a>
    </li>
    <li>
      <a href="../articles/A230-BOIN.html">BOIN - Bayesian Optimal Interval Design</a>
    </li>
    <li>
      <a href="../articles/A280-TITE.html">TITE-CRM and TITE-NBG - Time-to-Event Designs</a>
    </li>
    <li>
      <a href="../articles/A310-EfficacyToxicity.html">EffTox, Wages &amp; Tait, and BOIN12 - Efficacy &amp; Toxicity Designs</a>
    </li>
    <li>
      <a href="../articles/A360-Combinations.html">BOIN-COMB - Treatment Combination Designs</a>
    </li>
    <li>
      <a href="../articles/A600-DosePaths.html">Working with dose-paths</a>
    </li>
    <li>
      <a href="../articles/A700-Simulation.html">Simulating dose-escalation trials</a>
    </li>
    <li>
      <a href="../articles/A710-SimulationComparison.html">Comparing dose-escalation designs by simulation</a>
    </li>
  </ul></li>
<li>
  <a href="../news/index.html">Changelog</a>
</li>
      </ul><ul class="nav navbar-nav navbar-right"><li>
  <a href="https://github.com/brockk/escalation/" class="external-link">
    <span class="fab fa-github fa-lg"></span>

  </a>
</li>
      </ul></div><!--/.nav-collapse -->
  </div><!--/.container -->
</div><!--/.navbar -->



      </header><div class="row">
  <div class="col-md-9 contents">
    <div class="page-header">
    <h1>Select dose by the CIBP selection criterion.</h1>
    <small class="dont-index">Source: <a href="https://github.com/brockk/escalation/blob/HEAD/R/select_dose_by_cibp.R" class="external-link"><code>R/select_dose_by_cibp.R</code></a></small>
    <div class="hidden name"><code>select_dose_by_cibp.Rd</code></div>
    </div>

    <div class="ref-description">
    <p>This method selects dose by the convex infinite bounds penalisation (CIBP)
criterion of Mozgunov &amp; Jaki. Their method is mindful of the uncertainty in
the estimates of the probability of toxicity and uses an asymmetry parameter
to penalise escalation to risky doses.</p>
    </div>

    <div id="ref-usage">
    <div class="sourceCode"><pre class="sourceCode r"><code><span><span class="fu">select_dose_by_cibp</span><span class="op">(</span><span class="va">parent_selector_factory</span>, <span class="va">a</span>, target <span class="op">=</span> <span class="cn">NULL</span><span class="op">)</span></span></code></pre></div>
    </div>

    <div id="arguments">
    <h2>Arguments</h2>


<dl><dt id="arg-parent-selector-factory">parent_selector_factory<a class="anchor" aria-label="anchor" href="#arg-parent-selector-factory"></a></dt>
<dd><p>Object of type <code><a href="selector_factory.html">selector_factory</a></code>.</p></dd>


<dt id="arg-a">a<a class="anchor" aria-label="anchor" href="#arg-a"></a></dt>
<dd><p>Number between 0 and 2, the asymmetry parameter. See References.</p></dd>


<dt id="arg-target">target<a class="anchor" aria-label="anchor" href="#arg-target"></a></dt>
<dd><p>We seek a dose with this probability of toxicity. If not
provided, the value will be sought from the parent dose-selector.</p></dd>

</dl></div>
    <div id="value">
    <h2>Value</h2>
    <p>an object of type <code><a href="selector_factory.html">selector_factory</a></code> that can fit a
dose-finding model to outcomes.</p>
    </div>
    <div id="references">
    <h2>References</h2>
    <p>Mozgunov P, Jaki T. Improving safety of the continual reassessment method via
a modified allocation rule. Statistics in Medicine.1-17. doi:10.1002/sim.8450</p>
    </div>

    <div id="ref-examples">
    <h2>Examples</h2>
    <div class="sourceCode"><pre class="sourceCode r"><code><span class="r-in"><span><span class="va">skeleton</span> <span class="op">&lt;-</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="fl">0.05</span>, <span class="fl">0.1</span>, <span class="fl">0.25</span>, <span class="fl">0.4</span>, <span class="fl">0.6</span><span class="op">)</span></span></span>
<span class="r-in"><span><span class="va">target</span> <span class="op">&lt;-</span> <span class="fl">0.33</span></span></span>
<span class="r-in"><span></span></span>
<span class="r-in"><span><span class="co"># Let's compare escalation behaviour of a CRM model without CIBP criterion:</span></span></span>
<span class="r-in"><span><span class="va">model1</span> <span class="op">&lt;-</span> <span class="fu"><a href="get_dfcrm.html">get_dfcrm</a></span><span class="op">(</span>skeleton <span class="op">=</span> <span class="va">skeleton</span>, target <span class="op">=</span> <span class="va">target</span><span class="op">)</span></span></span>
<span class="r-in"><span><span class="co"># To one with the CIBP criterion:</span></span></span>
<span class="r-in"><span><span class="va">model2</span> <span class="op">&lt;-</span> <span class="fu"><a href="get_dfcrm.html">get_dfcrm</a></span><span class="op">(</span>skeleton <span class="op">=</span> <span class="va">skeleton</span>, target <span class="op">=</span> <span class="va">target</span><span class="op">)</span> <span class="op"><a href="https://magrittr.tidyverse.org/reference/pipe.html" class="external-link">%&gt;%</a></span></span></span>
<span class="r-in"><span>  <span class="fu">select_dose_by_cibp</span><span class="op">(</span>a <span class="op">=</span> <span class="fl">0.3</span><span class="op">)</span></span></span>
<span class="r-in"><span></span></span>
<span class="r-in"><span><span class="co"># Despite one-in-three tox at first dose, regular model is ready to escalate:</span></span></span>
<span class="r-in"><span><span class="va">model1</span> <span class="op"><a href="https://magrittr.tidyverse.org/reference/pipe.html" class="external-link">%&gt;%</a></span> <span class="fu"><a href="fit.html">fit</a></span><span class="op">(</span><span class="st">'1NTN'</span><span class="op">)</span> <span class="op"><a href="https://magrittr.tidyverse.org/reference/pipe.html" class="external-link">%&gt;%</a></span> <span class="fu"><a href="recommended_dose.html">recommended_dose</a></span><span class="op">(</span><span class="op">)</span></span></span>
<span class="r-out co"><span class="r-pr">#&gt;</span> [1] 2</span>
<span class="r-in"><span><span class="co"># But the model using CIBP is more risk averse:</span></span></span>
<span class="r-in"><span><span class="va">model2</span> <span class="op"><a href="https://magrittr.tidyverse.org/reference/pipe.html" class="external-link">%&gt;%</a></span> <span class="fu"><a href="fit.html">fit</a></span><span class="op">(</span><span class="st">'1NTN'</span><span class="op">)</span> <span class="op"><a href="https://magrittr.tidyverse.org/reference/pipe.html" class="external-link">%&gt;%</a></span> <span class="fu"><a href="recommended_dose.html">recommended_dose</a></span><span class="op">(</span><span class="op">)</span></span></span>
<span class="r-out co"><span class="r-pr">#&gt;</span> [1] 1</span>
<span class="r-in"><span></span></span>
</code></pre></div>
    </div>
  </div>
  <div class="col-md-3 hidden-xs hidden-sm" id="pkgdown-sidebar">
    <nav id="toc" data-toggle="toc" class="sticky-top"><h2 data-toc-skip>Contents</h2>
    </nav></div>
</div>


      <footer><div class="copyright">
  <p></p><p>Developed by Kristian Brock, Daniel Slade, Michael Sweeting.</p>
</div>

<div class="pkgdown">
  <p></p><p>Site built with <a href="https://pkgdown.r-lib.org/" class="external-link">pkgdown</a> 2.1.1.</p>
</div>

      </footer></div>






  </body></html>

